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Abstract: Vitiligo and alopecia areata present
an excellent opportunity to f ocus on the
effect of impaired appearance on the lives of
the persons with these diseases. Emotional
stress has precipitated vitiligo and alopecia
areata in some patients.
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Twenty-eight patients suffering from alopecia
areata and vitiligo and twenty healthy persons at ages between ten and sixty underwent psychological tests of examination with
special regard to verification of their psychi-

Introduction
The skin is an important organ, covering and
protecting the body against environmental hazards and
also providing the connection between the individual and
the environment. Some patients with cutaeneous
symptoms have psychological problems. Skin can react in
several ways against emotional factors.
A number of skin diseases are found to be related to
emotional factors. Alopecia areata and vitiligo are in this
group of diseases (1, 2).
Alopecia areata is a loss of hair with no appreciable
abnormality of the underlying skin, ranging in severity
from localized patches to universal involvement. The
cause of alopecia areata is unknown. Most evidence points
toward its being an autoimmune disease modified by
genetic factors and acquired by emotional stress (1, 3).
Vitiligo is associated with 4 percent of cases, and there is
a positive family history of alopecia in 10 percent of cases
o f vitiligo (4, 5).
Vitiligo is an acquired disorder in which areas of the
skin are completely lacking melanin pigmentation. The
cause of vitiligo is unknown, but abnormal neurogenic
stimuli, an enzymatic self-destruct mechanism, and an

atric symptoms. The results were compared
for all groups.
The results revealed that depressive symptomatology in patients with vitiligo and alopecia
areata was higher than in the control group
(respectively, 55%, 36%, 15%).
As a result, we conclude that the cosmetic
disfigurement may be of great importance on
the lives of persons with these diseases.
Key Words: Alopecia, Vitiligo, Psychosomatic
symptoms.

autoimmune mechanism have been postulated as
pathogenetic factors (4, 5).
The aim of the present study is to investigate the
psychiatric symptomology of alopecia areata and vitiligo.
Materials & Methods
The subject group was composed of 17 alopecia
patients and 11 vitiligo patients at the Fırat University
Faculty of Medicine Department of Dermatology. Of the
alopecia patients, 14 had localized and 3 had generalized
forms, and of the vitiligo patients, 9 had localized and 2
had generalized forms. Twenty patients were chosen for
the control group.
Psychometric values were determined by the Zung
Depression Scale and SCL-90-R (Symptom Check List 90R). Scales were filled out by subjects.
According to the Zung Depression Scale, a score of
fifty points or over shows clinical depression levels.
Results were compared with those of the control
group, composed of 20 dermatologically and
psychiatrically healthy individuals whose demographic
features were similar to those of the subject groups. The
results were evaluated by unpaired t-test.
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Depression Score

<50
>50
Total

Alopecia
n
%
11
6
17

Vitiligo

64
36
100

Table 1.

Control

n

%

n

%

5
6
11

45
55
100

17
3
20

85
15
100

Zung Depression Scale Values

Results

Discussion

The ages of the patients were between 10 and 60.
The mean age of the alopecia group was 26.47±12.2,
that of the vitiligo was 25.65±7, and that of the control
group was 27.09±14.6 years.

According to the results, patients with alopesia and
vitiligo had higher depressive and psychiatric symptoms
levels than the control group.

Table 1 shows the depression levels of the patients
and the control group according to the Zung Depression
Scale. Thirty-six percent of the patients with alopecia
areata, 55% of the patients with vitiligo, and 15% of the
control group manifested depressive symptomatology at
clinical levels.
SCL-90 R Scale results and the global severity index
value of patients and control group are given in Table 2.
There were significant differences in sub-scale values
of interpersonal relationship difficulties, depression,
anxiety, phobic reaction, paranoia and global severity
index between the alopecia group and the control group,
those o f the former being higher.
In all variables of SCL-90-R Sub-Scales, there were
significant differences between the vitiligo group and the
control group, but, exceptionally, in interpersonal
relationship difficulties and psychotism variables, there
were no significant differences (Table 2).
There were no significant differences in all variables of
SCL-90-R Sub-Scales between the alopecia and vitiligo
groups.
Alopecia

In both groups of patients, although the conditions do
not affect physical health of the patients, cosmetic
appearance effects their, psychological life negatively.
Similarly, Porter et al. have reported that many patients
are frightened and embarrassed by vitiligo (6).
Additionally, several investigators have pointed out the
relationship between depressive disordes and
psychosomatic skin diseases (2, 7, 8, 9).
In a study by Gürler et al. to investigate the psychiatric
symptomatology of Behçet’s disease, psoriasis and
alopecia, it was found that the patient group had more
severe psychiatric symptomatology than the control
group (10).
Although conflicting results have been reported by
some authors, emotional stress plays an important role in
most of the alopecia areata cases. Some of them accept
currently stress as a trigger factor in alpoecia (1, 11).
Although the exact etiology of those two diseases is
yet known, it is currently believed that immunological
mechanisms play an important role (1, 4, 5). Stress
affects the immunological mechanism differently. Acute
stres triggers immune response temporally. On the other

Vitiligo

Table 2.

Control

mean

sd

mean

sd

mean

sd

Somatisation

0.63

0.61

0.79*

0.53

0.35

0.36

Obsessive-compulsive features

0.94

0.54

0.90*

0.44

0.59

0.44

Irterpersonal relationship difficulties

1.05*

0.56

0.69

0.36

0.56

0.49

Depression

0.73*

0.55

0.64*

0.42

0.35

0.40

Anxiety

0.47*

0.36

0.70*

0.27

0.25

0.21

Nostility

0.80

0.57

0.84*

0.43

0.48

0.44

Phobic reaction

0.36*

0.39

0.42*

0.33

0.18

0.27

Paranoia

0.68*

0.41

0.43*

0.38

0.28

0.36

Psychotism

0.49

0.39

0.48

0.30

0.20

0.24

Addition scale

0.68

0.56

0.72*

0.34

0.43

0.32

Global severity index values

0.68*

0.40

0.67*

0.28

0.36

0.26

* Significant high values comparing with control group p<0.05
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hand, chronic or uncontrolled psychological stress
decreases the immune response in different phases (12,
13, 14, 15).

As a result, we conclude that apart from
dermatological examination and treatment, psychiatric
consultation and therapy may be helpful regarding vitiligo
and alopecia areata.
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